Our analysis of temporal stability of the urine proteome was restricted to prostate cancer patients that all have cISUP GG 1 tumors, similar serum PSA levels, and who did not have clinical upgrading over a period of 1–2 years. The gene discussed is KLK3; the disease is prostate carcinoma.